David Goldstein, MBBS, FRACP, FRCP (UK)

Department of Medical Oncology, Prince of Wales Hospital, Randwick, Australia

Prof Goldstein is a conjoint clinical professor in the Faculty of Medicine at the University of New South Wales and a Senior Staff Specialist in the Department of Medical Oncology, Prince of Wales Hospital, Randwick, Sydney, Australia. He has been involved in a variety of clinical research projects ranging from laboratory basic science to novel therapeutics trials to psychosocial aspects of Cancer care.

He has been principal investigator of a number of NHMRC and Cancer Australia funded therapeutic trials including both investigator initiated and as Australian PI for a number of multinational studies. He has also been involved with psychosocial and cross cultural/CALD research for many years. He has published and presented widely on both issues in Oncology nationally and internationally.

His clinical interests are treatment of GI malignancies including pancreas cancer, colorectal cancer, anal carcinoma, hepatobiliary and upper GI malignancy as well as renal cell carcinoma and lymphoma.

He is the adult program leader of the newly formed UNSW Cancer Survivors centre and is involved with a research program associated with survivorship issues. He also actively participates in three laboratory research programs dealing with stormal biology, drug resistance and modeling optimal targeted therapies in sarcoma.

Prof Goldstein is also a past President of the Clinical Oncology Society of Australia and is a director of the board. He has been a board member of the Australasian Gastrointestinal trials group for the past ten years and is currently treasurer of the group.

He has co-authored 184 peer reviewed publications and 200 overall. He is an active reviewer for many journals and funding bodies.

Terms of Appointment: August 2012 - December 2018; January 2019 - December 2020